Can Pretreatment Serum Beta-hCG be Used for Predicting Thyrotoxicosis in Gestational Trophoblastic Disease?

BACKGROUND: Gestational trophoblastic disease (GTD) comprises a diverse spectrum of entities of abnormal cellular proliferations originating in placental trophoblasts. The specific marker of GTD is beta-hCG which has a similar structure to the TSH molecule, interfering level of thyroid hormones. How...

Descripción completa

Detalles Bibliográficos
Autores principales: Khomphaiboonkij, Uraiwan, Termsarasab, Chanisorn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068195/
https://www.ncbi.nlm.nih.gov/pubmed/34837900
http://dx.doi.org/10.31557/APJCP.2021.22.11.3461

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9068195/
https://www.ncbi.nlm.nih.gov/pubmed/34837900
http://dx.doi.org/10.31557/APJCP.2021.22.11.3461

Ejemplares similares